Following stocks are close to their 52-week low as at 2.40 p.m. on March 22, 2018.

Engineering and architectural consultancy SS Infrastructure Development Consultants is buckling up to launch its initial public offering on the EMERGE platform of National Stock Exchange of India on March 28, 2018.

The markets on March 22, 2018 opened flat. BSE Sensex is trading at 33,116.86, down by 19.32 points and the Nifty is trading at 10,150.75, down by 4.50 points.

Suven Life Sciences secured product patents from Norway, South Korea and Singapore regulators corresponding to the New Chemical Entities (NCEs) for the treatment of disorders allied with Neurodegenerative diseases.

Zensar, an RPG company, is on the move to acquire the US-based Cynosure Inc. for US$33 million. Cynosure focuses on providing Guidewire platform implementation services to property and casualty (P&C) insurance carriers.

Market was buzzing with a possible tie-up between domestic budget carrier Indigo and Qatar Airways to buy debt-laden Indian national airlines Air-India.

After a huge run up in the last couple of years, the Indian markets are now in correction mode post the Union Budget 2018-19. This correction has led many stocks to give negative return year till date and have eaten into the returns of the investors.

Overall volumes in futures & options currently stand at 94.81 lakh contracts with a turnover of Rs. 8,14,332.32 crore.

Overall volumes in futures & options currently stand at 94.81 lakh contracts with a turnover of Rs. 8,14,332.32 crore.

Going ahead, the low of Wednesday’s session, i.e. 10,133, would be a crucial level to watch out as a decisive breach below this level would trigger some selling to re-test the 10,040-10,000 levels. Stocks in the news: Sun Pharmaceutical, Arvind, Dilip Buildcon, Zensar Technologies, Oil India, IRB Infrastructure and Majesco.